Pizzolo et al. [138] reported that the hypertension phenotype of apparent mineralocorticoid excess was associated with higher methylation of the HSD11B2 promoter region compared with normotensive heterozygous relatives. The gene discussed is HSD11B2; the disease is hypertensive disorder.